Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
Fondazione del Piemonte per l'Oncologia
Stanford University
National Cancer Institute (NCI)
Palo Alto Veterans Institute for Research
AstraZeneca
Jonsson Comprehensive Cancer Center
Intima Bioscience, Inc.
Karl Landsteiner University of Health Sciences
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Tizona Therapeutics, Inc
Institut Bergonié
Tribhuvan University, Nepal
Second Life Therapeutics
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Lantern Pharma Inc.
Tango Therapeutics, Inc.
Alaunos Therapeutics
Jonsson Comprehensive Cancer Center
NRG Oncology
Turning Point Therapeutics, Inc.
Pfizer
BerGenBio ASA
Stony Brook University
Shanghai Pulmonary Hospital, Shanghai, China
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Numab Therapeutics AG
Alliance for Clinical Trials in Oncology
Hacettepe University
SWOG Cancer Research Network
University of Pennsylvania
Emory University
Novartis